Dailypharm Live Search Close

Nicobreak ODF was approved for the first time in Korea

By Lee, Tak-Sun | translator Choi HeeYoung

21.04.14 12:04:22

°¡³ª´Ù¶ó 0
CTCBIO's Nicobreak ODF



CTC Bio's'Nicobreak ODF', a smoking cessation treatment that melts and eats, was approved for the first time in Korea. this. This product has been confirmed to be equivalent to the existing Champix (Varenicline, Pfizer), which is the same ingredient product.

The Ministry of Food and Drug Safety approved two items of Nicobreak ODF1mg/0.5mg of CTCBIO on the 13th. This product is a varenicline, such as Pfizer's Champix, and is used as an adjuvant therapy for smoking cessation.

In particular, this drug is the first ODF formulation in Korea that can be dissolved with the tongue without water. Conventional Varenicline tablets should be swallowed with water. Patients with difficulty swallowing o

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)